About Element Biosciences
Element Biosciences is a company based in San Diego (United States) founded in 2017 by Michael Previte and Molly He. Element Biosciences has raised $853.3 million across 8 funding rounds from investors including Fidelity Investments, Morgan Stanley and Samsung. Element Biosciences has completed 1 acquisition, including Element Biosciences. Element Biosciences offers products and services including AVITI24, Cloudbreak Sequencing Kits, Trinity Sequencing Kits, and ElemBio Cloud. Element Biosciences operates in a competitive market with competitors including 10X Genomics, DnaNudge, Laverock Therapeutics, Esya Labs and xMD, among others.
- Headquarter San Diego, United States
- Founders Michael Previte, Molly He
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$853.3 M (USD)
in 8 rounds
-
Latest Funding Round
$175 M (USD), Series E
Jun 09, 2026
-
Investors
Fidelity Investments
& 12 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Element Biosciences
Element Biosciences offers a comprehensive portfolio of products and services, including AVITI24, Cloudbreak Sequencing Kits, Trinity Sequencing Kits, and ElemBio Cloud.
Instrument for spatial co-detection of RNA, protein, and morphology in sequencing.
Kits for DNA and RNA sequencing applications in research.
Kits that simplify targeted sequencing workflows.
Software platform for managing sequencing data and analysis.
People of Element Biosciences
Unlock access to complete
Unlock access to complete
Software Development Team
24 people
Leadership Team
20 people
Sales and Marketing
18 people
Senior Team
13 people
Sr. Team
7 people
Product Management Team
7 people
Finance and Accounting
7 people
Operations Team
6 people
Unlock access to complete
Funding Insights of Element Biosciences
Element Biosciences has successfully raised a total of $853.3M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $175 million completed in June 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Element Biosciences
Element Biosciences has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Morgan Stanley and Samsung.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Locked | Locked | Locked | |
|
Multiple sectors are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Private equity fund focused on the biotechnology sector
|
Locked | Locked | Locked |
Investor details for Element Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Element Biosciences
Element Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Element Biosciences.
Investment portfolio details for Element Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
DNA sequencing technologies are developed for microbiome and genomic applications.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for Element Biosciences
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Element Biosciences
Detailed financials for Element Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Element Biosciences Comparisons
Peer comparison for Element Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Element Biosciences
Element Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, DnaNudge, Laverock Therapeutics, Esya Labs and xMD, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| Locked | Locked | Locked |
Lab-on-chip wearable systems for genetic diagnosis are provided.
|
|
| Locked | Locked | Locked |
Next-generation programmable cell therapies are developed using GEiGS technology.
|
|
| Locked | Locked | Locked |
Nanotechnology-based nucleic acid diagnostics are developed for early disease detection.
|
|
| Locked | Locked | Locked |
Laboratory instruments and consumables are developed for life science research.
|
Detailed competitors of Element Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Element Biosciences
Complete news archive for Element Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Element Biosciences
Element Biosciences was founded in 2017.
Element Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Molly He is the current CEO of Element Biosciences. They have also founded this company.
Element Biosciences is a funded company, having raised a total of $853.3M across 8 funding rounds to date.
Founded in 2017 and based in San Diego, United States, operations are centered in the biotechnology sector with a focus on genomics. Benchtop DNA sequencing technology is provided through the AVITI sequencer, which achieves high data quality via an enhanced contrast-to-noise ratio. Applications are targeted at research and diagnostic markets, supporting advancements in genetic analysis.
Element Biosciences's top competitors include 10X Genomics, Laverock Therapeutics and Esya Labs.
Element Biosciences offers AVITI24, Cloudbreak Sequencing Kits, Trinity Sequencing Kits, and ElemBio Cloud.
Element Biosciences has made 1 acquisition, including Element Biosciences.
Element Biosciences has 13 investors. Key investors include Fidelity Investments, Morgan Stanley, Samsung, T. Rowe Price, and HHS.